• Twitter Twitter
  • Email Email
  • Facebook Facebook
  • COPD Home
  • COPD Overview
    Overview
    • COPD Information
    • Health Economic Impact of COPD
  • Triple Aim in Practice
    Overview
    • Health System Solutions
    • Care Transitions
    • Health Information Technology
    • Quality Measures
  • Optimizing Care Delivery
    Overview
    • COPD Treatment Strategies
      Overview
      • GOLD Recommendations
      • COPD Delivery Options
    • Health Care Provider COPD Resources
    • In-Check™ DIAL G16
    • ICD-10 Code LookUp
    • Individualizing COPD Treatment
  • COPD Portfolio
    Overview
    • Dry-Powder Inhalers
      Overview
      • Utibron Neohaler
        Overview
        • Prescribing Information
        • Medication Guide
        • Instructions for Use
        • Clinical Study Results
        • Safety
        • Dosage and Administration
      • Seebri Neohaler
        Overview
        • Prescribing Information
        • Patient Information
        • INSTRUCTIONS FOR USE
        • Clinical Study Results
        • Safety
        • DOSAGE and ADMINISTRATION
      • Arcapta Neohaler
        Overview
        • Prescribing Information
        • Medication Guide
        • Instructions for Use
        • Dosing and Administration
    • VIBRATING MEMBRANE NEBULIZER
      Overview
      • Lonhala Magnair
        Overview
        • Prescribing Information
        • Patient Information
        • Instructions for Use
        • Clinical Study Results
        • Safety
        • Dosing and Administration
    • JET NEBULIZER
      Overview
      • Brovana
        Overview
        • Prescribing Information
        • Medication Guide
        • Instructions for Use
        • Clinical Study Results
        • Safety
        • Dosing and Administration
    • Health Care Provider Resources
    • Patient Resources

Resources to support Triple Aim goals

Learn how organizations are integrating new tools and technology into health care delivery.

  • Explore insights and resources for health system solutions

    Learn more about care transitions.

    GO NOW

  • Find out how information technology is transforming disease care

    Learn more about health information technology.

    GO NOW

Learn more about care transitions

 

 

 

 

 

 

 

 

 

 

 

 

Sunovion Sunovion

SUNOVION and   are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd.

XOPENEX HFA and BROVANA are registered trademarks of Sunovion Pharmaceuticals Inc.

APTIOM is a registered trademark of , used under license.  LATUDA is a registered trademark of Sumitomo Dainippon Pharma Co., Ltd.

ARCAPTA, ,  UTIBRON, , SEEBRI, , and NEOHALER are registered trademarks of Novartis AG, used under license. 

LONHALA and   are registered trademarks of Sunovion Pharmaceuticals Inc. MAGNAIR is a registered trademark of PARI Pharma GmbH, used under license.

eFlow and eLete are registered trademarks of PARI Pharma GmbH.

This site contains information intended for U.S. formulary decision-makers only.

© 2019 Sunovion Pharmaceuticals Inc. All rights reserved. 07/18 RESP052-18

  • About
  • Contact Us
  • Terms of Use
  • Privacy and Cookie Notice
  • Medical Disclaimer
  • Submit a Medical Inquiry
  • Glossary

Share With a Friend

Here's your message:

Please find a link below to Sunovion Health Insights, a website designed specifically for payers and population health managers: www.sunovionhealthinsights.com

Please note that Sunovion Pharmaceuticals Inc. will not retain or use you or your friend's email address when sharing this information.

Thanks For Sharing!

select a disease state